Uploaded November 2025 | Updated September 2026, 3 weeks ago
GLP-1 drugs and next-generation metabolic hormone combinations are transforming the food and health landscape. Kim Fisher, Director of Programs at the UC Davis Innovation Institute for Food and Health, shares some data on metabolic hormone therapies like Ozempic, Wegovy, Mounjaro and Zepbound. She explains some of the current clinical trials for GLP-1 drugs, how they are being used and what can be expected in the future.
The Science of Metabolic Hormones: Precision Nutrition in the “Ozempic Era” is a forum that took place at UC Davis' Sacramento campus on October 6-7, 2025. Guided by leading UC Davis researchers, the forum explored how deep scientific understanding of metabolic hormones like GLP-1s can inspire a new wave of innovation—shaping the future of food for health in meaningful, lasting ways.
This video includes an audio description track. To hear the narration of important on-screen information, turn on "English Descriptive" in the player’s settings menu.
Watch more lectures from this series: youtube.com/playlist?list=PLM7qvIv8N9Rs9ZS45aOkKzekHGnothOE4
Learn more about GLP-1 and health: https://health.ucdavis.edu/news/headlines/glp-1-and-health-beyond-weight-loss-in-the-ozempic-era/2025/11
UC Davis Innovation Institute for Food and Health: https://foodandhealth.ucdavis.edu/
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
0:00 Introduction
1:04 Obesity in America
2:09 Current use of GLP-1/GIP medications in U.S.
3:05 Current metabolic hormone therapies
4:18 Clinical studies -- What's next?
6:56 Potential market for GLP-1 drugs
7:38 Will drugs like Ozempic get more affordable?
8:54 International market for GLP-1 drugs
10:21 Consumption changes on a GLP-1 medication
12:07 How will GLP-1 drugs affect dessert industry?
13:13 Conclusion
The information in this video was accurate as of the recording date, 10/6/25. For information purposes only. Consult your local medical authority for advice.
#glp1 #glp1medications #ozempic #weightloss #ucdavis
GLP-1 drugs and next-generation metabolic hormone combinations are transforming the food and health landscape. Kim Fisher, Director of Programs at the UC Davis Innovation Institute for Food and Health, shares some data on metabolic hormone therapies like Ozempic, Wegovy, Mounjaro and Zepbound. She explains some of the current clinical trials for GLP-1 drugs, how they are being used and what can be expected in the future.
The Science of Metabolic Hormones: Precision Nutrition in the “Ozempic Era” is a forum that took place at UC Davis' Sacramento campus on October 6-7, 2025. Guided by leading UC Davis researchers, the forum explored how deep scientific understanding of metabolic hormones like GLP-1s can inspire a new wave of innovation—shaping the future of food for health in meaningful, lasting ways.
This video includes an audio description track. To hear the narration of important on-screen information, turn on "English Descriptive" in the player’s settings menu.
Watch more lectures from this series: youtube.com/playlist?list=PLM7qvIv8N9Rs9ZS45aOkKzekHGnothOE4
Learn more about GLP-1 and health: https://health.ucdavis.edu/news/headlines/glp-1-and-health-beyond-weight-loss-in-the-ozempic-era/2025/11
UC Davis Innovation Institute for Food and Health: https://foodandhealth.ucdavis.edu/
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
0:00 Introduction
1:04 Obesity in America
2:09 Current use of GLP-1/GIP medications in U.S.
3:05 Current metabolic hormone therapies
4:18 Clinical studies -- What's next?
6:56 Potential market for GLP-1 drugs
7:38 Will drugs like Ozempic get more affordable?
8:54 International market for GLP-1 drugs
10:21 Consumption changes on a GLP-1 medication
12:07 How will GLP-1 drugs affect dessert industry?
13:13 Conclusion
The information in this video was accurate as of the recording date, 10/6/25. For information purposes only. Consult your local medical authority for advice.
#glp1 #glp1medications #ozempic #weightloss #ucdavis
